
CRISERNA helps researchers and biotech teams design safer, more effective genome editing solutions. It uses AI-assisted in silico CRISPR design, ethical and regulatory strategy, and bespoke applications in oncology, rare disease, and agriculture. The team includes researchers and bioethicists with experience in target discovery, 3D organoid models, and computational biology, serving as a B2B consultancy. CRISERNA targets research labs, startups, and translational groups seeking responsible, scalable genome editing capabilities.

CRISERNA helps researchers and biotech teams design safer, more effective genome editing solutions. It uses AI-assisted in silico CRISPR design, ethical and regulatory strategy, and bespoke applications in oncology, rare disease, and agriculture. The team includes researchers and bioethicists with experience in target discovery, 3D organoid models, and computational biology, serving as a B2B consultancy. CRISERNA targets research labs, startups, and translational groups seeking responsible, scalable genome editing capabilities.